Zebrafish Male vs Female: Why Sex Matters in Drug Discovery and Preclinical Models

Sex is a critical variable influencing physiology, behavior, and pharmacological responses across species. For many years, sex was often overlooked as a biological variable in preclinical studies, with experiments frequently conducted using mixed or unsexed populations. However, growing evidence shows that sex-specific differences can significantly shape biological processes and drug responses. 

How to Identify Male and Female Zebrafish in Laboratory Settings

Accurate zebrafish gender identification is the first step in incorporating sex as a biological variable. Adult zebrafish exhibit several distinguishing morphological traits: females are generally larger with a rounded abdomen and a prominent genital papilla due to egg development, while males are more slender and display brighter yellow or orange pigmentation, particularly in their anal fins. Males also tend to have thicker pectoral fin rays and a more streamlined body shape. These external features, however, are highly dependent on the observer's experience and are not always seen or expressed. 

To increase accuracy, we can perform morphometric analyses. Geometric morphometrics analyzes the shape of anatomical structures using specific landmarks, allowing for the detection of subtle morphological differences between male and female zebrafish with high precision. It has demonstrated accuracy rates of up to 95–100% in sexing adult zebrafish, which is particularly valuable for high-throughput screening. 

Sex-Dependent Differences in Behavior and Physiology: Implications for Drug Response

Sexual dimorphism in zebrafish extends beyond external appearance, influencing brain organization, neurochemistry, and behavior, factors that directly affect how drugs work. Males typically show higher exploratory behavior, aggression, and boldness, whereas females demonstrate stronger social cohesion and enhanced memory acquisition in some cognitive tasks. These differences correspond with neurochemical variations: females often exhibit higher dopamine concentrations in specific brain regions, while serotonin levels and metabolites differ significantly between sexes.

At the physiological level, male and female brains display distinct cellular and hormonal patterns. For example, female zebrafish show increased neurogenesis in certain telencephalic regions, while males exhibit higher activity in hypothalamic zones. Hormonal profiles also diverge: estradiol concentrations are moderately higher in female brains, whereas the potent androgen 11-ketotestosterone can be more than twice as high in males. These hormonal dynamics influence drug responses, as demonstrated by experiments where male zebrafish mating behavior was suppressed by estradiol exposure and female reproductive activity decreased following androgen treatment. Even withdrawal responses can vary: cocaine withdrawal triggers anxiety earlier in females, but is more persistent and severe in males. 

Anxiety-like behaviours further illustrate how sex shapes zebrafish responses in preclinical studies. Females often display heightened anxiety levels in standard assays such as the novel tank test, spending more time at the bottom and showing reduced exploratory activity compared with males. 

These findings demonstrate that sex can shape everything from neural signaling pathways to drug metabolism. Ignoring these variables risks misinterpreting experimental outcomes and limiting the translational value of preclinical data.

Why Ignoring Zebrafish Sex Can Undermine Efficacy Testing and Safety Data

Neglecting sex as a biological variable can significantly distort experimental outcomes. Numerous studies have demonstrated that toxicants, environmental disruptors, and therapeutic compounds produce sex-specific effects in zebrafish. For instance, bisphenol A (BPA) alters locomotor activity and circadian behavior in males but not in females. Atrazine exposure disrupts serotonergic signaling in female larvae, while certain pesticides affect gene expression in a sex-specific manner. If experiments pool male and female data or fail to report sex differences, these effects can be masked, leading to misleading efficacy and toxicity conclusions.

Such biases can be particularly problematic in drug discovery, where sex differences in neurotransmission and hormone signaling critically influence therapeutic outcomes. Inconsistent responses between sexes could explain variability in preclinical efficacy testing or unanticipated side effects in clinical trials. Moreover, some sex-dependent effects are heritable across generations, such as the exposure to fluoxetine, an antidepressant drug, which suppresses cortisol levels in adult zebrafish, and the effect persists for three consecutive generations, especially in males. This means that unrecognized variables may influence future generations of test animals and confound longitudinal studies. 

Best Practices for Incorporating Sex as a Biological Variable in Zebrafish Preclinical Studies

To harness the full predictive potential of zebrafish models, sex must be integrated systematically throughout experimental design and analysis. The first step is rigorous sex identification and balanced group allocation. Both sexes should be included in pharmacological testing, and data should be analyzed separately to uncover sex-specific trends. Experimental timing should also consider hormonal cycles and developmental stages, as fluctuations can significantly affect results.

Zebrafish behavioral assays should be designed and analyzed with sex differences in mind, acknowledging that baseline activity, stress reactivity, and cognitive performance vary between males and females. Reporting standards should include detailed information on sex distribution, identification methods, and sex-specific results to facilitate reproducibility and cross-study comparison.

Sexual dimorphism in zebrafish affects how these organisms respond to drugs and metabolize compounds. From neurobiology and behavior to hormonal dynamics and gene expression, male and female zebrafish exhibit profound differences that shape preclinical outcomes. Incorporating sex as a standard variable in study design improves the accuracy, reproducibility, and translational relevance of zebrafish research, ultimately enabling more reliable and effective drug development pipelines.

References

Duff NM, Sommerfeld RE, Litvak MK. Discriminating Sex in Zebrafish (Danio rerio) Using Geometric Morphometrics. Zebrafish. 2019 Apr;16(2):207-213. doi: 10.1089/zeb.2018.1664.

Genario R, de Abreu MS, Giacomini ACVV, Demin KA, Kalueff AV. Sex differences in behavior and neuropharmacology of zebrafish. Eur J Neurosci. 2020 Jul;52(1):2586-2603. doi: 10.1111/ejn.14438.

Hillman, C., Fontana, B.D., Amstislavskaya, T.G. et al. Housing and husbandry factors affecting zebrafish novel tank test responses: a global multi-laboratory study. Lab Anim. 2025;54, 156–164. doi:10.1038/s41684-025-01548-x

Zhai G, Jia J, Bereketoglu C, Yin Z, Pradhan A. Sex-specific differences in zebrafish brains. Biol Sex Differ. 2022 Jun 17;13(1):31. doi: 10.1186/s13293-022-00442-2.

By Miriam Martínez

Miriam is a Human Biologist with a strong background in neuropharmacology and a passion for bridging science and innovation. After earning a master’s degree in the Pharmaceutical and Biotech Industry, she completed her PhD in Biomedicine at Pompeu Fabra University (Barcelona), where her research focused on the behavioral analysis of animal models for neurophenotypical characterization. Following her doctoral studies, Miriam transitioned into the healthcare marketing and communication sector, where she played a key role in developing impactful marketing strategies and educational campaigns for leading pharmaceutical brands. She now leverages her scientific expertise, strategic thinking, and creative communication skills in her current role at ZeClinics.